The Cancer Therapeutics Market was valued at US$ 230.42 Billion in 2024 and is projected to reach US$ 531.53 Billion by 2031, registering a CAGR of 12.68% during 2025–2031. This version emphasizes balanced demand, technology, competition, and execution. Decision-makers should connect market growth to verified customer needs, operating constraints, and measurable value. What is driving the...